HSBC Holdings’s Kite Pharma, Inc. KITE Stock Holding History

HSBC Holdings’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,657	Closed	-$478K	–	2506
2017 Q3	$478K	Sell	2,657 -31,653	-92%	-$4.41M	﹤0.01%	1734
2017 Q2	$3.56M	Buy	34,310 +13,580	+66%	+$1.11M	0.01%	1084
2017 Q1	$1.66M	Buy	20,730 +9,775	+89%	+$604K	﹤0.01%	1267
2016 Q4	$491K	Buy	10,955 +6,644	+154%	+$326K	﹤0.01%	1854
2016 Q3	$240K	Buy	+4,311	New	+$240K	﹤0.01%	1847
2015 Q3	–	Sell	-3,371	Closed	-$205K	–	2265
2015 Q2	$205K	Buy	+3,371	New	+$192K	﹤0.01%	1828

HSBC Holdings's KITE Position: Q4 2017 in Review

HSBC Holdings sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,657 shares — an estimated $478K sold.

HSBC Holdings first reported a position in KITE in Q2 2015 and held it in 6 quarters. The position peaked at $3.56M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

HSBC Holdings reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
HSBC Holdings sold 2,657 Kite Pharma, Inc. shares in Q4 2017, an estimated $478K.
HSBC Holdings first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 6 quarters.
HSBC Holdings's Kite Pharma, Inc. position peaked at $3.56M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on HSBC Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.